期刊文献+

MiR-138对MCF-7细胞端粒酶活性及端粒稳定性的调控作用 被引量:1

The regulation of telomerase activity and telomere stability by MiR-138 in MCF-7 cells
下载PDF
导出
摘要 目的研究MiR-138通过人端粒酶反转录酶(hTERT)作为下游靶基因,对人乳腺癌MCF-7细胞端粒酶活性的调控作用及端粒稳定性的影响。方法在人乳腺癌MCF-7细胞中瞬时转染MiR-138模拟物,用MTT法检测细胞增殖活性,并于转染后48 h用实时定量RT-PCR检测端粒酶催化亚单位hTERT表达、TRAP assay检测端粒酶活性,同时对细胞进行53BP1抗体免疫荧光染色及端粒的FISH染色。结果转染后48 h,MiR-138模拟物处理的MCF-7细胞hTERT表达水平比对照细胞降低2.18倍(2-△△Ct),端粒酶活性比对照细胞降低2.69倍,53BP1聚集形成的凝集点(Foci)部分与端粒位点重合,比率达到20.62%±1.55%。结论 MiR-138以hTERT作为下游靶分子调控MCF-7细胞端粒酶活性,影响细胞端粒稳定性。 Objective To study the regulation mechanism of telomerase activity of MiR-138 by targeting hTERT as the downstream molecular,and its effect on telomere stability in breast cancer cell line MCF-7.Methods MiR-138 mimics were transiently transfected into breast cancer cell line MCF-7.MTT method was applied for detecting the effect on cell proliferation.The hTERT expression level of the cells was detected by real-time RT-PCR and telomerase activity was checked by TRAP assay 48 h after transfection.Meanwhile,the cells were simultaneously checked by 53BP1 antibody immunofluorescent staining and telomere FISH staining.Results The hTERT expression level of MCF-7 cells treated with MiR-138 was repressed by 2.18 folds(2-△△Ct) when compared with the control cells 48 h after transfection.Telomerase activity was also decreased by 2.69 folds when compare with the control cells.53BP1congregated into many Foci and co-localized with the telomere spots at a percentage of 20.62%±1.55%.Conclusion MiR-138 can regulate telomerase activity in MCF-7 cells by targeting hTERT as the downstream molecular,and affects the telomere stability as well.
出处 《基础医学与临床》 CSCD 北大核心 2010年第8期826-830,共5页 Basic and Clinical Medicine
基金 广东省科技计划(2009B060700112)
关键词 MiR-138 端粒酶 端粒 人乳腺癌MCF-7细胞 MiR-138 telomerase telomere human breast cancer cell line MCF-7
  • 相关文献

参考文献10

  • 1Hobert O. Gene regulation by transcription factors and microRNAs [ J ]. Science, 2008, 319 (5871 ) : 1785 - 1786.
  • 2宋宝,宋现让,刘杰,魏玲.miRNAs及其靶基因的识别[J].基础医学与临床,2007,27(9):1063-1065. 被引量:6
  • 3Esquela-Kerscher A, Slack FJ. Oneomirs - microRNAs with a role in cancer[J]. Nat Rev Cancer, 2006, 6(4) :259 - 269.
  • 4峗淑莉,张世能.肿瘤干细胞与肿瘤靶向治疗[J].基础医学与临床,2008,28(9):914-919. 被引量:2
  • 5宋宝,宋现让,魏玲.microRNA与人类肿瘤[J].基础医学与临床,2007,27(10):1181-1184. 被引量:2
  • 6Mitomo S, Maesawa C, Ogasawara S, et al. Downregulation of MiR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines [ J ]. Cancer Sci, 2008, 99(2):280 -286.
  • 7Liu Xiqiang, Jiang Lu, Wang Anxun, et al. MieroRNA- 138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines [ J ]. Cancer Lett, 2009, 286(2) :217 -222.
  • 8Zhao Xiaohong, Yang Li, Hu Jianguo, et al. MiR-138 might reverse multidrug resistance of leukemia ceils [ J ]. Leuk Res, 2010, 34(8): 1078- 1082.
  • 9Baykal A, Rosen D, Zhou C, et al. Telomerase in breast cancer: a critical evaluation [ J ]. Adv Anat Pathol, 2004, 11(5) :262 -268.
  • 10Phatak P, Burger AM. Telomerase and its potential for therapeutic intervention[J]. Br J Pharmaeol, 2007, 152 (7) :1003 - 1011.

二级参考文献27

  • 1Clement V Sanchez P de Tribolet N Radovanovic I Ruiz i Altaba A.HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity[J].中国神经肿瘤杂志,2007,5(2):122-122. 被引量:96
  • 2Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to linl4 [ J ]. Cell, 1993,75 (5) :843 - 854.
  • 3Jackson R J, Standart N. How do microRNAs regulate gene expression? [J]. Sci STXE,2007,2(367) :34 -41.
  • 4Ambros V,Bartel B,Bartel DP,et al. A uniform system for microRNA annotation [ J ]. RNA, 2003,9 (3) :277 - 279.
  • 5Makarev E, Spence JR, Del Rio-Tsonis K, et al. Identification of microRNAs and other small RNAs from the adult newt eye[ J]. Mol Vis, 2006,12 : 1386 - 1391.
  • 6Sunkar R,Girke T,Jain PK,et al. Cloning and characterization of microRNAs from rice[J]. Plant Ce11,2005,17(5) : 1397 - 1411.
  • 7Chatterjee R,Chaudhuri K. An approach for the identification of microRNA with an application to Anopheles gambiae [ J ]. Acta Biochim Pol, 2006,53 (2) : 303 - 309.
  • 8Cui C, Griffiths A, Li G, et al. Prediction and identification of herpes simplex virus 1-encoded microRNAs[ J]. J Virol, 2006,80( 11 ) :5499 - 5508.
  • 9John B, Sander C, Marks DS,et al. Prediction of human microRNA targets [ J ]. Methods Mol Biol, 2006,342 : 101 - 113.
  • 10Thadani R, Tammi MT. MicroTar: predicting microRNA targets from RNA duplexes [ J ]. BMC Bioinformatics,2006, 7(5) :S20.

共引文献7

同被引文献16

  • 1Zurita M, Lara PC, del Moral R, et al. Hypermethylated 14-3-3-σ and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis [J]. BMC Cancer, 2010, 10: 217- 226.
  • 2Heneghan HM, Miller N, Lowery AJ, et al. MicroRNAs as novel biomarkers for breast cancer [ J ]. J Oncol, 2009, 2009 : 950201.
  • 3Shering SG, Sherry F, McDermott EW, et al. Preoperative CA15-3 concentrations predict outcome of patients with breast carcinoma [J]. Cancer, 1998, 83:2521 -2527.
  • 4Velaiutham S, Taib NA, Ng KL, et al. Does the pre-operative value of serum CA15-3 correlate with survival in breast cancer [ J]. Asian Pac J Cancer Prev, 2008, 9:445 - 448.
  • 5Weigel MT, Dowsett M. Current and emerging biomarkers in breast cancer: prognosis and prediction [ J]. Endocr Relat Cancer, 2010, 17:245-262.
  • 6Bramwell VH, Doig GS, Tuck AB, et al. Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer [J]. Breast Cancer Res Treat, 2009, 114:503 -511.
  • 7Nishimura R, Osako T, Okumura Y, et al. Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers be- tween primary and recurrent breast cancer: discordance rates and prognosis [J]. World J Surg Oncol, 2011, 9: 131 - 137.
  • 8F.u SW, Chen L, Man YG. miRNA biomarkers in breast cancer detection and management [ J]. J Cancer, 2011, 2: 116-122.
  • 9Castafieda CA, Agullo-Ortuno MT, Fresno JA, et al. Implication of miRNA in the diagnosis and treatment of breast cancer [ J ]. Expert Rev Anticancer Ther, 2011, 11 : 1265 - 1275.
  • 10Hiller DJ, Meschonat C, Kim R, et al. Chemokine receptor CXCR4 level in primary tumors independently predicts outcome for patients with locally advanced breast cancer [J]. Surgery, 2011, 150:459-465.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部